AKT1 and melanoma: Knocking down LncRNA H19 expression can reduce the phosphorylation expression of phosphoinositide 3 kinase (PI3K), protein kinase B (Akt) and IκBα, prevent the migration and invasion of melanoma cells from the nuclear translocation of p-p65 and activate the NF-κB signaling pathway [23,24].